SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-17-003483
Filing Date
2017-06-05
Accepted
2017-06-05 21:59:47
Documents
1
Period of Report
2017-06-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4_edick060517.html 4  
1 OWNERSHIP DOCUMENT f4_edick060517.xml 4 5532
  Complete submission text file 0001171843-17-003483.txt   6893
Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Issuer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEWLINK GENETICS CORP. 2503 SOUTH LOOP DR., SUITE 5100 AMES IA 50010
Business Address
Edick Paul R (Reporting) CIK: 0001531178 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33609 | Film No.: 17892945